Navellier & Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-41,237
| Closed | -$16.9M | – | 331 |
|
|
2022
Q1 | $16.9M | Sell |
41,237
-1,639
| -4% | -$673K | 2.88% | 2 |
|
|
2021
Q4 | $20.1M | Buy |
42,876
+209
| +0.5% | +$98K | 2.93% | 2 |
|
|
2021
Q3 | $18.1M | Buy |
42,667
+19,972
| +88% | +$8.48M | 2.73% | 2 |
|
|
2021
Q2 | $8.15M | Buy |
22,695
+1,761
| +8% | +$632K | 1.23% | 15 |
|
|
2021
Q1 | $5.9M | Buy |
20,934
+2,667
| +15% | +$752K | 1.06% | 28 |
|
|
2020
Q4 | $5.18M | Buy |
18,267
+2,044
| +13% | +$579K | 0.94% | 31 |
|
|
2020
Q3 | $4.46M | Buy |
+16,223
| New | +$4.46M | 0.97% | 31 |
|
|
2017
Q2 | – | Sell |
-55,652
| Closed | -$4.54M | – | 333 |
|
|
2017
Q1 | $4.54M | Buy |
55,652
+1,979
| +4% | +$162K | 0.66% | 60 |
|
|
2016
Q4 | $4.55M | Sell |
53,673
-5,992
| -10% | -$508K | 0.75% | 47 |
|
|
2016
Q3 | $4.45M | Buy |
59,665
+6,344
| +12% | +$473K | 0.64% | 56 |
|
|
2016
Q2 | $4.05M | Buy |
+53,321
| New | +$4.05M | 0.6% | 52 |
|
|
2014
Q1 | – | Sell |
-47,472
| Closed | -$2.33M | – | 351 |
|
|
2013
Q4 | $2.33M | Buy |
+47,472
| New | +$2.33M | 0.11% | 53 |
|